News originally posted at Baystreet.ca

Sunshine Biopharma Inc. (OTC PINK: SBFM), a pharmaceutical company focused on the research, development, and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed negotiations of the terms of the previously announced private placement with its exclusive placement agent, Jitney Trade Inc. The offering will consist of up to 400,000,000 shares of the Company’s Common Stock at a price of $0.025 Canadian (approximately $0.02 US) per share (the “Shares”) for gross proceeds of up to $10,000,000 Canadian (approximately $8,000,000 US) (the “Offering”). If fully subscribed, the Shares will represent approximately 30.3% of the Company on a post Offering basis.

Management is very pleased with the outcome of the negotiations, as it believes that the current trading price of the Common Stock does not reflect the real value of…

See the entire news release.